tiprankstipranks
Trending News
More News >
NFL Biosciences SA (FR:ALNFL)
FRANKFURT:ALNFL
France Market

NFL Biosciences SA (ALNFL) Income Statement

Compare
1 Followers

NFL Biosciences SA Income Statement

Last quarter (Q2 2023), NFL Biosciences SA's total revenue was €0.00, a decrease of ― from previous quarter. In Q2, NFL Biosciences SA's net income was €-2.11M. See NFL Biosciences SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 46.00€ 200.01K€ 0.00€ 39.00€ 3.00
Gross Profit
€ -67.14K€ -56.06K€ -2.24M€ -530.73K€ -169.36K
Operating Expenses
€ 2.72M€ 4.37M€ 668.96K€ 371.17K€ 148.67K
Depreciation and Amortization
€ 67.14K€ 56.06K€ 52.44K€ 43.50K€ 41.96K
EBITDA
€ -2.65M€ -4.05M€ -2.81M€ -1.08M€ -271.09K
Operating Income
€ -2.79M€ -4.43M€ -3.01M€ -901.87K€ -318.03K
Other Income/Expenses
€ 73.84K€ 318.55K€ 152.22K€ -217.64K€ 4.98K
Pretax Income
€ -2.72M€ -4.11M€ -2.86M€ -1.12M€ -313.04K
Net Income
€ -2.08M€ -3.75M€ -2.44M€ -978.24K€ -266.49K
Per Share Metrics
Basic EPS
€ -0.21€ -0.46€ -0.47€ -0.19€ -0.05
Diluted EPS
€ -0.21€ -0.46€ -0.47€ -0.19€ -0.05
Weighted Average Shares Outstanding
9.83M 8.11M 5.23M 5.23M 5.23M
Weighted Average Shares Outstanding (Diluted)
9.83M 8.11M 5.23M 5.23M 5.23M
Currency in EUR

NFL Biosciences SA Earnings and Revenue History